Reckitt Benckiser Group plc (LON:RKT – Get Free Report) insider Deepak Nath bought 257 shares of the business’s stock in a transaction dated Tuesday, June 23rd. The stock was acquired at an average cost of GBX 4,650 per share, for a total transaction of £11,950.50.
Reckitt Benckiser Group Stock Performance
LON:RKT traded up GBX 53 during trading hours on Thursday, reaching GBX 4,831. 10,399,414 shares of the company’s stock were exchanged, compared to its average volume of 23,735,174. Reckitt Benckiser Group plc has a 1-year low of GBX 3,866 and a 1-year high of GBX 6,522.92. The company has a quick ratio of 0.46, a current ratio of 0.85 and a debt-to-equity ratio of 108.83. The firm has a market capitalization of £30.76 billion, a price-to-earnings ratio of 9.93, a P/E/G ratio of 1.10 and a beta of 0.29. The company has a 50-day moving average of GBX 4,683.63 and a 200 day moving average of GBX 5,453.26.
Analyst Ratings Changes
RKT has been the topic of several recent research reports. Citigroup dropped their price target on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Jefferies Financial Group reissued a “hold” rating and issued a GBX 5,600 target price on shares of Reckitt Benckiser Group in a report on Tuesday, June 16th. Berenberg Bank cut their price target on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating for the company in a research note on Friday, April 24th. Royal Bank Of Canada reiterated a “neutral” rating and issued a GBX 6,200 price objective on shares of Reckitt Benckiser Group in a research report on Friday, May 15th. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Reckitt Benckiser Group from GBX 5,460 to GBX 5,430 and set a “hold” rating on the stock in a research note on Tuesday, April 28th. Three analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of GBX 6,204.29.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- Getty Images’ OpenAI Deal Gives the Stock a New AI Licensing Story
- Cerebras Systems, Inc: The Next Rags-to-Riches AI Story?
- Micron’s HBM Surge Could Redefine the AI Growth Story
- Qualcomm’s $4B AI Deal Takes Aim at NVIDIA’s Software Moat
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
